NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
--
--(--)
6.79 / 10
Outperform
Analyst sentiment is bullish: two recent Buy ratings (JP Morgan, Wolfe Research) with JP Morgan showing an 80% win rate. Fund‑flow score is 7.86/10, small/medium investors net positive, while large blocks show outflows, yielding a mixed but overall favorable capital flow.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-12
InstitutionJP Morgan
Times predicted5
Historical Win Rate80.0%
What is the analyst consensus for NBIX?
- NBIX holds a Bullish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.79/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
